FIELD: medicine.
SUBSTANCE: present invention refers to a spray drying production process of a solid pharmaceutical powder containing microcrystalline cellulose in a solid dispersion of the anti-HIV compound etravirine (TMC125) in a water-soluble polymer. In a parent mixture, the relation of the water-soluble polymer to TMC 125 makes 10:1 to 1:1, and of microcrystalline cellulose to TMC 125 - 1:1 to 1:3. Said parent mixture of microcrystalline cellulose, a solution of the water-soluble polymer and etravirine is sprayed in the form of drops into a drying chamber by atomisers to form a solid dispersion of TMC 125 powder.
EFFECT: better solubility and bioavailability of the antiviral compound etravirine.
10 cl, 9 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS CONTAINING DIACEREIN | 2009 |
|
RU2542461C2 |
POWDERS FOR PREPARING LIQUID DOSAGE FORM | 2008 |
|
RU2477133C2 |
SOLID DISPERSIONS AND PHARMACEUTICAL COMPOSITIONS INCLUDING SUBSTITUTED INDANE, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF | 2019 |
|
RU2772693C1 |
PHARMACEUTICAL COMPOSITIONS | 1996 |
|
RU2159107C2 |
SOLID DISPERSIONS | 2016 |
|
RU2694832C2 |
SOLID MOLECULAR DISPERSION | 2012 |
|
RU2600816C2 |
SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING INTEGRASE INHIBITOR | 2010 |
|
RU2602865C2 |
GRANULES HAVING NUCLEUS COATED WITH ANTIFUNGAL PREPARATION AND POLYMER | 1999 |
|
RU2219909C2 |
PHARMACEUTICAL COMPOSITION OF PYRAZOLE COMPOUND DISPERSED IN POLYMER MATRIX | 2020 |
|
RU2826604C1 |
PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2809144C2 |
Authors
Dates
2010-12-20—Published
2007-06-06—Filed